Response to Comments: Molecular Pathology Procedures

This document is an administrative notice describing the public comment process for the Molecular Pathology Procedures LCD (policy A55334). It states that the official notice period began on October 13, 2016 and the final LCD became effective December 1, 2016; it does not itself define clinical coverage, limitations, or frequency limits.

"National Government Services solicited public and provider comments on the draft Molecular Pathology Procedures LCD; the official notice period began October 13, 2016 and the final determination be..."

Sign up to see full coverage criteria, indications, and limitations.